Research Article
The Pattern of Juvenile Idiopathic Arthritis in a Single Tertiary Center in Saudi Arabia
Table 5
Pharmacologic therapy used in JIA patients.
| | | Oligo.
JIA = 23 | Poly. RF-neg. = 20 | Poly. RF-Pos. = 4 | SoJIA = 30 | ERA = 1 | Psoriatic = 4 | Total = 82 (%) |
| | NSAIDs alone | 6 | 2 | 0 | 0 | 1 | 0 | 9 (10.97) | | NSAIDs, AC | 4 | 2 | 0 | 0 | 0 | 0 | 6 (7.31) | | NSAIDs, IAC, MTX | 3 | 0 | 1 | 0 | 0 | 0 | 4 (4.87) | | NSAIDs, steroids | 1 | 0 | 0 | 5 | 0 | 0 | 6 (7.31) | | NSAIDs, MTX | 5 | 0 | 1 | 3 | 0 | 3 | 12 (14.63) | | NSAIDs, MTX, steroids | 0 | 6 | 0 | 7 | 0 | 1 | 14 (17) | | NSAIDs, MTX, biologics | 1 | 5 | 1 | 1 | 0 | 0 | 8 (9.75) | | NSAIDs, MTX, biologics, steroids | 2 | 4 | 0 | 13 | 0 | 0 | 19 (23.17) | | NSAIADs, MTX, biologics, IAC | 1 | 1 | 1 | 1 | 0 | 0 | 4 (4.87) | | Joint surgery | 1 | 1 | 1 | 0 | 0 | 0 | 3 (3.65) |
|
|
NSAIDs: Nonsteroidal anti-inflammatory drugs, IAC: intra-articular corticosteroids, and MTX: methotrexate.
|
